Pfizer Leaders Discuss the Adoption of Open Source, Predominantly R, in Clinical Trial Reporting

In this PHUSE video interview, Pfizer is making strides in incorporating open source tools into its clinical reporting processes. Michael Rimler, PHUSE Open Source Technologies Director, brings in Mike Smith,…
The post Pfizer Leaders Discuss the Adoption of Open Source, Predominantly R, in Clinical Trial Reporting appeared first on R …